Advertisement

A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine

      Abstract

      Background

      There is considerable interest in developing new multipurpose prevention technologies to address women's reproductive health needs. This study describes an innovative barrier contraceptive device ��� based on the SILCS diaphragm ��� that also provides long-term controlled release of the lead candidate anti-HIV microbicide dapivirine.

      Study Design

      Diaphragm devices comprising various dapivirine-loaded polymer spring cores overmolded with a nonmedicated silicone elastomer sheath were fabricated by injection molding processes. In vitro release testing, thermal analysis and mechanical characterization were performed on the devices.

      Results

      A diaphragm device containing a polyoxymethylene spring core loaded with 10% w/w dapivirine provided continuous and controlled release of dapivirine over a 6-month period, with a mean in vitro daily release rate of 174 mcg/day. The mechanical properties of the new diaphragm were closely matched to the SILCS diaphragm.

      Conclusions

      The study demonstrates proof of concept for a dapivirine-releasing diaphragm with daily release quantities potentially capable of preventing HIV transmission. In discontinuous clinical use, release of dapivirine may be readily extended over 1 or more years.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sinding S.W.
        What has happened to family planning since Cairo and what are the prospects for the future?.
        Contraception. 2008; 78: S3-S6
        • Cates Jr., W.
        Contraception, unintended pregnancies, and sexually transmitted diseases: why isn't a simple solution possible?.
        Am J Epidemiol. 1996; 143: 311-318
        • Cates Jr., W.
        • Steiner M.J.
        Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach?.
        Sex Transm Dis. 2002; 29: 168-174
        • Thurman A.R.
        • Clark M.R.
        • Doncel G.F.
        Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies.
        Infect Diseas Obstet Gynecol. 2011; (Article ID 429403)
        • Kulczycki A.
        • Qu H.
        • Bosarge P.M.
        • Shewchuk R.M.
        Barriers to diaphragm use: the views of advanced practice nurses.
        J Fam Plann Reprod Health Care. 2010; 36: 79-82
        • Bat��r I.
        • Sivin I.
        State-of-the-art of non-hormonal methods of contraception: I. Mechanical barrier contraception.
        Eur J Contracept Reprod Health Care. 2010; 15: 67-88
        • Schwartz J.L.
        • Ballagh S.A.
        • Creinin M.D.
        • et al.
        SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
        Contraception. 2008; 78: 237-244
        • Yang C.C.
        • Maravilla K.R.
        • Kilbourne-Brook M.
        • Austin G.
        Magnetic resonance imaging of SILCS diaphragm: anatomical considerations and corroboration with clinical fit.
        Contraception. 2007; 76: 238-244
        • Coffey P.S.
        • Kilbourne-Brook M.
        • Brache V.
        • Coch��n L.
        Comparative acceptability of the SILCS and Ortho ALL-FLEX�� diaphragms among couples in the Dominican Republic.
        Contraception. 2008; 78: 418-423
        • Coffey P.S.
        • Kilbourne-Brook M.
        • Beksinska M.
        • Thongkrajai E.
        Short-term acceptability of a single-size diaphragm among couples in South Africa and Thailand.
        J Fam Plann Reprod Health Care. 2008; 34: 233-236
        • Coffey P.S.
        • Kilbourne-Brook M.
        Wear and care of the SILCS diaphragm: experience from three countries.
        Sex Health. 2010; 7: 159-164
        • Frezieres R.G.
        • Walsh T.
        • Kilbourne-Brook M.
        • Coffey P.S.
        Couples' acceptability of the SILCS diaphragm for microbicide delivery.
        Contraception. 2012; 85: 99-107
        • Schwartz J.L.
        • Weiner D.
        • Lai J.-J.
        • et al.
        Contraceptive efficacy, safety and acceptability of SILCS, a novel single-sized diaphragm used with contraceptive gel.
        Contraception. 2012; 85: 327
        • Malcolm R.K.
        • Woolfson A.D.
        • Toner C.F.
        • et al.
        Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.
        J Antimicrob Chemother. 2005; 56: 954-956
        • Nel A.
        • Smythe S.
        • Young K.
        • et al.
        Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women.
        J Acquir Immune Defic Syndr. 2009; 51: 416-423
        • Bershtein V.A.
        • Egorova L.M.
        • Egorov V.M.
        • et al.
        Segmental dynamics in poly(oxymethylene) as studied via combined differential scanning calorimetry/creep rate spectroscopy approach.
        Thermochimica Acta. 2002; 391: 227-243
        • Nel A.M.
        • Coplan P.
        • van de Wijgert J.H.
        • et al.
        Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
        AIDS. 2009; 23: 1531-1538
        • Fletcher P.
        • Harman S.
        • Azijn H.
        Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor.
        Antimicrob Agents Chemother. 2009; 53: 487-495
        • Romano R.
        • Variano B.
        • Coplan P.
        • et al.
        Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring.
        AIDS Res Hum Retroviruses. 2009; 25: 483-488
        • Gupta K.M.
        • Pearce S.M.
        • Poursaid A.E.
        • et al.
        Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.
        J Pharm Sci. 2008; 97: 4228-4239
        • Woolfson A.D.
        • Malcolm R.K.
        • Toner C.F.
        • et al.
        Potential use of vaginal rings for prevention of heterosexual transmission of HIV: a controlled-release strategy for HIV microbicides.
        Am J Drug Deliv. 2006; 4: 7-20
        • Johnson T.J.
        • Gupta K.M.
        • Fabian J.
        • et al.
        Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir.
        Eur J Pharm Sci. 2010; 39: 203-212
        • Malcolm R.K.
        • Edwards K.-L.
        • Kiser P.
        • et al.
        Advances in microbicide vaginal rings.
        Antiviral Res. 2010; 88: S30-S39
        • Nuttall J.P.
        • Thake D.C.
        • Lewis M.G.
        • et al.
        Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.
        Antimicrob Agents Chemother. 2008; 52: 909-914
        • Nel A.M.
        • Smythe S.C.
        • Habibi S.
        • et al.
        Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. hydroxyethyl cellulose-based universal placebo gel.
        JAIDS. 2010; 55: 161-169
        • Nel A.M.
        • Coplan P.
        • Smythe S.C.
        • et al.
        Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
        AIDS Res Hum Retrovir. 2010; 26: 1181-1190
        • Penman-Aguilar A.
        • Swezey T.
        • Turner A.N.
        • et al.
        Promoting continuous use as a strategy for achieving adherence in a trial of the diaphragm with candidate microbicide.
        AIDS Educ Prev. 2009; 21: 512-525
        • Behets F.
        • Norris Turner A.
        • Van Damme K.
        • et al.
        Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar.
        Sex Transm Infect. 2005; 81: 472-476
        • Ferreira A.E.
        • Ara��jo M.J.
        • Regina C.H.
        • et al.
        Effectiveness of the diaphragm, used continuously, without spermicide.
        Contraception. 1993; 48: 29-35
        • Call V.
        • Sprecher S.
        • Schwartz P.
        The incidence and frequency of marital sex in a national sample.
        J Marriage Family. 1995; 57: 639-652
        • Jauffr��s D.
        • Lame O.
        • Vigier G.
        • et al.
        Mechanical and physical characterization of polyoxymethylene processed by high-velocity compaction.
        J App Polym Sci. 2007; 106: 488-497
        • Jebawi K.A.
        • Sixou B.
        • S��gu��la R.
        • et al.
        Hot compaction of polyoxymethylene, part 1: processing and mechanical evaluation.
        J App Polym Sci. 2006; 102: 1274-1284
        • Sauer B.B.
        • Avakian P.
        • Flexman E.A.
        • et al.
        A.C. dielectric and TSC studies of constrained amorphous motions in flexible polymers including poly (oxymethylene) and miscible blends.
        J Polym Sci B. 1997; 35: 2121-2132